News and information about basic science that may lead researchers to develop a cure for HIV – studies of the latent viral reservoir, shock and kill approaches, gene therapies, immune modulators therapeutic vaccines, broadly neutralizing antibodies and so on.

The search for a cure: latest news

The search for a cure resources

The search for a cure features

The search for a cure news from aidsmap

More news

The search for a cure news selected from other sources

  • Rapid HIV Rebound in Semen After Antiretroviral Treatment Interruption

    “Overall, the rapid and intense HIV-RNA rebound observed very early, both in blood and semen, after ATI [antiretroviral treatment interruption] emphasizes the need for targeted prevention strategies to reduce the risk of sexual transmission during all the trials involving treatment interruptions,” co-lead authors Dr. Romain Palich, MD, and Constance Delaugerre, MD, PhD, both from Université Paris Diderot, France, and colleagues, write.

    01 November 2018 | Contagion Live
  • STEPS V: HIV cure community workshop in Glasgow

    STEPS, a community initiative to design the pathway to a long-term remission of HIV infection, has reached its 5th edition in Glasgow. This year the theme of the meeting that was held just before the opening of the HIV Drug Therapy Congress was ‘socio-behavioural science and ethics around HIV cure research’.

    01 November 2018 | EATG
  • ‘Fear overcome by love’: why I participated in HIV cure research

    Researchers may not know me, but they know my blood cells. I am participant 2512 of the Observational Study of the Consequences of the Protease Inhibitor Era (SCOPE). I was told that my case of HIV was discovered at the earliest stage of infection in history. This is not the life accomplishment that I would want to be remembered for. However, when I found out, I did want to help my fellow human beings.

    22 October 2018 | Journal of Virus Eradication
  • Second case of potential HIV eradication

    One of the highlights of the BHIVA Autumn Conference, slipped in as a couple of slides at the end of the meeting, was that the UK might have a second potential case of HIV eradication (although this is one of the presentations is one that is not online).

    22 October 2018 | HIV i-Base
  • Gilead and Aelix join forces to pursue HIV 'cure'

    Gilead Sciences – already a giant in HIV therapy – has teamed up with Spanish biotech Aelix Therapeutics to try to develop a treatment regimen that would go beyond controlling the virus and provide an effective cure for the infection.

    18 October 2018 | PMLiVE
  • Vedolizumab could be used to target latent HIV harboring in gut

    Vedolizumab, a first-line treatment for inflammatory bowel disease that targets the alpha4beta7 protein, might be an important tool in the search for a cure for HIV, according to research published in Science Translational Medicine.

    04 October 2018 | Healio
  • No 'reservoir': Detectable HIV-1 in treated human liver cells found to be inert

    Novel study suggests HIV-1 still detectable in human liver macrophages unlikely to stay infectious after long-term antiretroviral therapy.

    02 October 2018 | Science Daily
  • Powerful antibodies suppress HIV for months, could simplify treatment

    Two studies in small numbers of people show for the first time that infusions of two powerful anti-HIV antibodies can completely suppress the virus for several months.

    28 September 2018 | Science
  • Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

    Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously treated with antiretroviral therapy (ART). The study appears September 21st in the journal Molecular Therapy.

    24 September 2018 | Science Daily
  • Investigators Uncover Details About A Rare Group of HIV Patients

    A pair of new studies is shedding light on a rare, but scientifically important, group of people with HIV who are able to maintain viral control even after stopping antiretroviral therapy. Clues about this ability may help improve antiretroviral therapy, which currently most patients with HIV must receive for life.

    24 September 2018 | MD Magazine
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.